Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Organogenesis Holdings Inc (Organogenesis) is a regenerative medicine company that develops, manufactures and commercializes solutions for advanced wound care, surgical and sports medicine. The company’s products include Affinity, FiberOS, OCMP, PuraPly SX, PuraPly MZ, PuraForce and CYGNUS Matrix. Its dermagraft is used for the treatment of diabetic foot ulcers. Organogenesis’s apligraf is used for the treatment of venous leg ulcers and diabetic foot ulcers. The company products treat in area orthopedic and neurosurgical such as spinal fusions and foot and ankle fusions. Organogenesis serves hospitals, wound care centers, government facilities, ambulatory service centers and physician offices. It has operations in Switzerland and the US. Organogenesis is headquartered in Canton, Massachusetts, the US.
Headquarters
United States of America
Address
85 Dan Road, Canton, Massachusetts, 02021-2810
Website
ww.organogenesis.com
Telephone
1 781 5750775
No of Employees
869
Industry
Medical Equipment
Ticker Symbol & Exchange
ORGO (NASD)
Revenue (2024)
$482.0M
11.3%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-82.6%
(2024 vs 2023)
Market Cap*
$317.8M
Net Profit Margin (2024)
XYZ
-84.2%
(2024 vs 2023)
* As of and is in US$
Products and Services
| Products | Brands |
|---|---|
| Affinity | Affinity |
| FiberOS | FiberOS |
| OCMP | PuraForce |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | Organogenesis Holdings Inc | Integra LifeSciences Holdings Corp | MiMedx Group Inc | Vericel Corp | PolyNovo Ltd |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | Australia |
| City | Canton | Princeton | Marietta | Cambridge | Melbourne |
| State/Province | Massachusetts | New Jersey | Georgia | Massachusetts | Victoria |
| No. of Employees | 869 | 4,396 | 837 | 357 | 301 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Gary S. Gillheeney | President; Chief Executive Officer; Chairman | Executive Board | 2014 | 70 |
| David C. Francisco | Chief Financial Officer | Senior Management | 2021 | 59 |
| Patrick Bilbo | Chief Operating Officer | Senior Management | 2017 | 63 |
| Lori Freedman | Chief Administrative Officer | Senior Management | 2013 | 58 |
| Robert Cavorsi | Vice President - Strategy | Senior Management | 2021 | 46 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer